(Informaci\u00f3n remitida por la empresa firmante)<\/p>\n
\nGr\u00fcnenthal PRO is joining SHL Medical\u2019s alliance partnership network to offer final assembly service for Molly* autoinjectors<\/p>\n
\nNEWS AKTUELL \/\/ Aachen, Germany.- Gr\u00fcnenthal PRO, the contract development and manufacturing organization (CDMO) division of Gr\u00fcnenthal offering a range of services including final assembly of autoinjectors, is entering into a non-exclusive partnership with SHL Medical, a world-leading solutions provider of advanced drug delivery systems. Through this collaboration, Gr\u00fcnenthal PRO will offer final assembly, packaging and labelling of Molly* autoinjector. <\/p>\n
\nGr\u00fcnenthal PRO will expand its capacity for final assembly of SHL autoinjectors by installing additional assembly lines in its Origgio, Italy facility in 2026. These new pre-validated lines for Molly* 1.0 and 2.25 mL autoinjector platform will enhance speed-to-market for pharma and biotech companies, building on Gr\u00fcnenthal\u2019s 10 year-experience in SHL autoinjector assembly services.<\/p>\n
\nIn parallel, SHL customers will benefit from access to Gr\u00fcnenthal PRO\u2019s established expertise and capacity in delivering high quality, reliable contract manufacturing services. <\/p>\n
\n\u201cSpeed-to-market is a decisive advantage in today\u2019s biopharma landscape,\u201d says Victor Barbosa, Executive Vice President of Global Operations at Gr\u00fcnenthal. \u201cWith our deep expertise in autoinjector final assembly and the new high-speed line launching in 2026, Gr\u00fcnenthal is uniquely positioned to deliver agile, large-scale solutions. Our collaboration with SHL enhances this capability, reinforcing our role as a trusted CDMO partner for injectable therapies worldwide.\u201d<\/p>\n
\nMolly* is a single-dose autoinjector built on modular platform technology that helps pharma and biotech companies reduce initial investments and accelerate timelines. Molly* boasts an unparalleled track record in combination product approvals and is designed to meet the evolving requirements of future autoinjectors.<\/p>\n
\nMarkus Puusepp, SHL Medical\u2019s Chief Growth Officer, commented on the collaboration: \u201cThis new partnership builds on several years of successful project collaboration between SHL Medical and Gr\u00fcnenthal PRO for joint customers. We\u2019re excited to deepen our collaboration by officially welcoming Gr\u00fcnenthal PRO as a strategic partner, further strengthening our trusted relationship.\u201d<\/p>\n
\nThe new Molly* autoinjector assembly line to be installed by Gr\u00fcnenthal PRO will be procured from SHL Advantec, a sub-group of SHL Medical and global provider of high-performance, fully integrated precision tooling and advanced automation solutions for the healthcare sector and other industries. <\/p>\n
\nAbout SHL Medical <\/p>\n
\nAs a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by its company purpose \u2013 Enabling Patients\u2019 Independence \u2013 SHL Medical offers patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. It also offers final assembly, labeling, and packaging solutions for its drug delivery systems. <\/p>\n
\nLocated across Switzerland, Taiwan, Sweden, and the US, SHL Medical\u2019s global team of experts collaborate seamlessly as one team in utilizing its comprehensive in-house manufacturing capabilities. Its solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into its designs and processes to contribute to a cleaner earth. <\/p>\n
\nFor additional information, visit http:\/\/www.shl-medical.com\/<\/p>\n
\nAbout Gr\u00fcnenthal PRO<\/p>\n
\nGr\u00fcnenthal PRO is the contract manufacturing division of Gr\u00fcnenthal, offering end-to-end services in pharmaceutical assembly, packaging, and labelling. With a strong focus on injectable therapies and advanced automation, Gr\u00fcnenthal PRO supports global pharma and biotech companies in accelerating time-to-market and ensuring high-quality delivery. For more information, visit www.grunenthal-pro.com.<\/p>\n
\nFor additional information, visit www.grunenthal-pro.com<\/p>\n
\nSHL<\/p>\n
\nMedia contact <\/p>\n
\nChristine Mueller<\/p>\n
\nCorporate Communications<\/p>\n
\ninfo@shl-medical.com <\/p>\n
\n+41 41 368 00 00 <\/p>\n
\nGr\u00fcnenthal PRO <\/p>\n
\nMedia contact<\/p>\n
\nGr\u00fcnenthal PRO Communications<\/p>\n
\ninfo@grunenthal-pro.com<\/p>\n
\n+49 (0)241 569-0<\/p>\n
\nhttps:\/\/www.grunenthal-pro.com\/contact-us<\/p>\n","protected":false},"excerpt":{"rendered":"
(Informaci\u00f3n remitida por la empresa firmante) Gr\u00fcnenthal PRO is joining SHL Medical\u2019s alliance partnership network to offer final assembly service for Molly* autoinjectors NEWS AKTUELL \/\/ Aachen, Germany.- Gr\u00fcnenthal PRO, the contract development and manufacturing organization (CDMO) division of Gr\u00fcnenthal offering a range of services including final assembly of autoinjectors, is entering into a non-exclusive […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-63280","post","type-post","status-publish","format-standard","hentry","category-noticias"],"_links":{"self":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/63280","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=63280"}],"version-history":[{"count":0,"href":"https:\/\/webciudadana.net\/index.php?rest_route=\/wp\/v2\/posts\/63280\/revisions"}],"wp:attachment":[{"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=63280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=63280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/webciudadana.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=63280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}